These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10796314)

  • 41. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack.
    Sandercock PA; Gibson LM; Liu M
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD000248. PubMed ID: 19370555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral antiplatelet therapy for acute ischaemic stroke.
    Sandercock PA; Counsell C; Tseng MC; Cecconi E
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD000029. PubMed ID: 24668137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transient atrial fibrillation and risk of stroke after acute myocardial infarction.
    Bishara R; Telman G; Bahouth F; Lessick J; Aronson D
    Thromb Haemost; 2011 Nov; 106(5):877-84. PubMed ID: 21866303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1273-7. PubMed ID: 9565007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct oral anticoagulants in the secondary prevention of stroke and transient ischemic attack in patients with atrial fibrillation.
    Arnao V; Agnelli G; Paciaroni M
    Intern Emerg Med; 2015 Aug; 10(5):555-60. PubMed ID: 25862436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable.
    Connolly SJ; Eikelboom JW; Ng J; Hirsh J; Yusuf S; Pogue J; de Caterina R; Hohnloser S; Hart RG;
    Ann Intern Med; 2011 Nov; 155(9):579-86. PubMed ID: 22041946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiplatelet Regimen for Patients With Breakthrough Strokes While on Aspirin: A Systematic Review and Meta-Analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Stroke; 2017 Sep; 48(9):2610-2613. PubMed ID: 28701574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial.
    Verma A; Ha ACT; Kirchhof P; Hindricks G; Healey JS; Hill MD; Sharma M; Wyse DG; Champagne J; Essebag V; Wells G; Gupta D; Heidbuchel H; Sanders P; Birnie DH
    Am Heart J; 2018 Mar; 197():124-132. PubMed ID: 29447772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.
    Lip GY; Lanitis T; Mardekian J; Kongnakorn T; Phatak H; Dorian P
    Stroke; 2015 Oct; 46(10):2830-7. PubMed ID: 26316345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Atrial fibrillation and stroke].
    Mattle HP; Schwerzmann M; Seiler Ch
    Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antithrombotic treatment of cerebrovascular disease.
    Oczkowski WJ; Turpie AG
    Baillieres Clin Haematol; 1990 Jul; 3(3):781-813. PubMed ID: 2271790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial.
    Hart RG; Pearce LA; Koudstaal PJ
    Stroke; 2004 Apr; 35(4):948-51. PubMed ID: 14988571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcome after stroke due to atrial fibrillation.
    Mattle HP
    Cerebrovasc Dis; 2003; 16 Suppl 1():3-8. PubMed ID: 12698012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
    Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation.
    Manaktala R; Kluger J
    J Am Osteopath Assoc; 2017 Dec; 117(12):761-771. PubMed ID: 29181519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269].
    Mant JW; Richards SH; Hobbs FD; Fitzmaurice D; Lip GY; Murray E; Banting M; Fletcher K; Rahman J; Allan T; Raftery J; Bryan S;
    BMC Cardiovasc Disord; 2003 Aug; 3():9. PubMed ID: 12939169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.
    Tentschert S; Parigger S; Dorda V; Bittner K; Unterbuchschachner D; Greisenegger S; Wimmer R; Brücke T; Lang W; Lalouschek W;
    Wien Klin Wochenschr; 2004 Dec; 116(24):834-8. PubMed ID: 15690967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.